Cancer Chemotherapy and Pharmacology,volume 59,issue 1  (01-2007)

Period of time: 2007年1期

Publisher: Springer Publishing Company

Founded in: 1978

Total resources: 46

ISSN: 0344-5704

Subject: R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Cancer Chemotherapy and Pharmacology,volume 59,issue 1

Menu

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer

By Park Keon,Ahn Jin,Park Young,Lee Jeeyun,Kang Jung,Park Joon,Lim Ho,Im Young-Hyuck,Kang Won,Park Keunchil,Lee Soon in (2007)

Cancer Chemotherapy and Pharmacology,volume 59,issue 1 , Vol. 59, Iss. 1, 2007-01 , pp. 17-21

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Thalidomide and celecoxib as potential modulators of irinotecan’s activity in cancer patients

By Villalona-Calero Miguel,Schaaf Larry,Phillips Gary,Otterson Gregory,Panico Kevin,Duan Wenrui,Kleiber Barbara,Shah Manisha,Young Donn,Wu Wan-Hong,Kuhn John in (2007)

Cancer Chemotherapy and Pharmacology,volume 59,issue 1 , Vol. 59, Iss. 1, 2007-01 , pp. 23-33

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens

By Kosmas Christos,Tsavaris Nicolas,Syrigos Konstantinos,Koutras Angelos,Tsakonas George,Makatsoris Thomas,Mylonakis Nicolas,Karabelis Athanasios,Stathopoulos George,Kalofonos Haralambos in (2007)

Cancer Chemotherapy and Pharmacology,volume 59,issue 1 , Vol. 59, Iss. 1, 2007-01 , pp. 51-59

Springer Publishing Company

Abstract Access to resources Recommend Favorite